Neo-Bladder Augmentation for Neurogenic Bladder

MD
Overseen ByMary-Clare Day, RN, BSN
Age: 18 - 65
Sex: Any
Trial Phase: Phase 2
Sponsor: Wake Forest University Health Sciences
Must be taking: Anticholinergics
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new treatment called the "neo-bladder" construct for individuals with a fibrotic or contracted bladder, which holds little urine and can cause high pressure. The goal is to determine if this new bladder pouch can safely improve urine collection over time. Ideal candidates for this trial are those who have tried medications but still experience bladder issues and require surgery to prevent kidney problems. Participants should be capable of performing tasks like catheterization and bladder cycling. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group of people.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, it mentions that participants should have failed to respond to the maximum approved dose of medical therapy or have a contraindication to such agents, which might imply some changes to your current medication regimen.

What prior data suggests that the neo-bladder construct is safe for treating neurogenic bladder?

Research has shown that treatments similar to the neo-bladder construct, such as surgeries to enlarge the bladder, have been well-received by patients. These procedures can increase bladder size and reduce pressure, helping to protect the kidneys over time. In one study, more than half of the patients reported moderate to extreme satisfaction with their treatment results.

However, some risks require consideration. The most common issue was the development of a vesicourethral fistula, a small, unusual connection that can form between the bladder and the urethra, occurring in about 15% of patients. Despite this, the treatment generally maintained good kidney health. This suggests that the neo-bladder construct could be a safe option, but discussing these potential risks with a healthcare provider is important.12345

Why do researchers think this study treatment might be promising?

Unlike the standard treatment options for neurogenic bladder, which often include medications or traditional bladder augmentation surgeries, the Neo-Bladder Construct is unique because it's made from the patient’s own tissue. This personalized approach aims to create a new bladder that is more compatible with the body, potentially reducing the risk of rejection and complications. Researchers are excited about this treatment because it could provide a more natural and long-lasting solution for patients with fibrotic contracted bladders, helping to prevent severe complications like kidney failure by effectively managing high bladder pressures.

What evidence suggests that the Neo-Bladder Construct might be an effective treatment for neurogenic bladder?

Research has shown that bladder augmentation, a treatment similar to the neo-bladder construct studied in this trial, can significantly increase bladder size and reduce pressure in patients with neurogenic bladder. In some cases, the bladder's ability to stretch and hold urine improved by up to 179% after surgery. Patients who previously received an autologous neo-bladder construct reported moderate to excellent satisfaction with their results. These findings suggest that the neo-bladder construct could effectively increase bladder capacity and lower pressure, which is important for preventing kidney problems.13467

Who Is on the Research Team?

RJ

Robert J Evans, MD

Principal Investigator

Atrium Health Wake Forest Baptist

Are You a Good Fit for This Trial?

This trial is for individuals with a neurogenic bladder who have not responded to standard medical treatments and are able to perform self-catheterization. They must have a small bladder capacity (<150cc) or poor bladder compliance, and be willing to consent in English. Excluded are those with recent surgeries, infections like HIV/HBV/HCV/TB, allergies to certain materials, drug abuse history, pregnant or breastfeeding women, and those on certain medications.

Inclusion Criteria

My bladder is small and/or scarred but not due to nerve issues.
Willing and able to give signed informed consent in English
I have had new kidney or bladder issues in the last year.
See 5 more

Exclusion Criteria

Prior participation in the study
Current incarceration for any reason
I am not pregnant, planning to become pregnant, or breastfeeding.
See 26 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Cell Expansion and Neo-Bladder Construction

Participants undergo a bladder biopsy, and cells are expanded ex vivo to create the neo-bladder construct

5-7 weeks

Surgical Implantation

The neo-bladder construct is surgically implanted onto the native bladder during augmentation cystoplasty

1 week

Follow-up

Participants are monitored for safety and effectiveness after treatment

36 months

What Are the Treatments Tested in This Trial?

Interventions

  • Neo-Bladder Construct
Trial Overview The study tests an autologous 'neo-bladder' construct surgically attached to the patient's bladder as a new treatment method for improving urine collection in patients with fibrotic or contracted bladders. The safety and effectiveness of this neo-bladder will be evaluated over time.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Autologous "Neo-Bladder" ConstructExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+

Citations

Augmentation Cystoplasty Using an Autologous Neo ...The purpose of this research study is to find out if autologous "neo-bladder" construct for the treatment of fibrotic and/or contracted bladder can improve ...
Neo-Bladder Augmentation for Neurogenic BladderResearch shows that bladder augmentation, a similar treatment, can significantly increase bladder capacity and reduce pressure in patients with neurogenic ...
a systematic reviewThe bladder compliance increased by 15%, 67%, and 179% postoperatively in the C, C + O, and PC + O implants, respectively. Moreover, the bladder ...
Long-term Outcomes of Augmentation Enterocystoplasty in ...Fifty-four patients (52.9%) reported moderate to excellent satisfaction with the outcome, and there were no significant differences among the groups (P=0.430).
Bladder augmentation using an autologous neo-bladder constructA 17-year-old boy developed a small-capacity neurogenic bladder following excision of a conus medullaris dermoid cyst (Figure 1a). This resulted in elevated ...
Augmentation Cystoplasty Using an Autologous Neo-Bladder ...Also called a data safety ... contracted bladder can improve bladder compliance and be safe long term. ... All subjects will have non-neurogenic, fibrotic ...
Long-term outcomes of urinary tract reconstruction in ...All patients had good preservation of upper tract status. The most common post-operative complication was the formation of a vesicourethral fistula in 15% of ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security